Spotlight on Proteases: Roles in Ovarian Health and Disease
- PMID: 40558552
- PMCID: PMC12190606
- DOI: 10.3390/cells14120921
Spotlight on Proteases: Roles in Ovarian Health and Disease
Abstract
Proteases play crucial roles in ovarian folliculogenesis, regulating several processes from primordial follicle activation to ovulation and corpus luteum formation. This review synthesizes the current knowledge on the diverse functions of proteases in ovarian physiology and pathology. We discuss the classification and regulation of proteases, highlighting their importance in extracellular matrix remodeling, cell signaling, and apoptosis during ovarian follicular development. We explore the roles of several proteases including matrix metalloproteinases, tissue inhibitors of metalloproteinases, the plasminogen activator system, and cathepsins, and their roles in the critical functions of ovarian biology including follicle dynamics and senescence. Furthermore, we address the involvement of proteases in ovarian pathologies, including cancer, polycystic ovary syndrome, and primary ovarian insufficiency. By integrating recent findings from clinical genomics and animal models, this review provides a comprehensive overview of protease functions in the ovary, emphasizing their potential use for therapeutic interventions in reproductive medicine.
Keywords: cathepsins; matrix metalloproteinases; ovarian cancer; ovarian reserve; ovary; polycystic ovary syndrome; primary ovarian insufficiency; proteases.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
The roles of MAPK signaling pathway in ovarian folliculogenesis.J Ovarian Res. 2025 Jul 14;18(1):152. doi: 10.1186/s13048-025-01737-9. J Ovarian Res. 2025. PMID: 40660328 Free PMC article. Review.
-
Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.Cochrane Database Syst Rev. 2012 Jun 13;(6):CD001122. doi: 10.1002/14651858.CD001122.pub4. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2020 Feb 11;2:CD001122. doi: 10.1002/14651858.CD001122.pub5. PMID: 22696324 Updated.
-
Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2018 May 24;5(5):CD010287. doi: 10.1002/14651858.CD010287.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2022 Sep 27;9:CD010287. doi: 10.1002/14651858.CD010287.pub4. PMID: 29797697 Free PMC article. Updated.
-
A systematic review of tests predicting ovarian reserve and IVF outcome.Hum Reprod Update. 2006 Nov-Dec;12(6):685-718. doi: 10.1093/humupd/dml034. Epub 2006 Aug 4. Hum Reprod Update. 2006. PMID: 16891297
-
Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome.Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD010287. doi: 10.1002/14651858.CD010287.pub4. Cochrane Database Syst Rev. 2022. PMID: 36165742 Free PMC article.
References
-
- Levene P.A. The Cleavage Products of Proteoses. J. Biol. Chem. 1905;1:45–58. doi: 10.1016/S0021-9258(17)46095-9. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical